GOLDMAN SACHS GROUP INC

Holdings History for Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Symbol: SLXN on Nasdaq
Investment type: Equity / Ordinary shares, par value $0.0135 per share
Latest Disclosed Shares Owned: 211,945 shares
Security Ownership %: 2.4%

THE GOLDMAN SACHS GROUP, INC. ownership in Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)

13 May 2025 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 211,945 shares of Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN). This represents 2.4% ownership of the company. In their previous filing dated 10 Feb 2025, GOLDMAN SACHS GROUP INC had reported owning 112,242 shares, indicating an increase of +89%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
THE GOLDMAN SACHS GROUP, INC.	2.4%	-60%	$197,109	211,945	+99,703	+89%	$0.93	13G/A	31 Mar 2025	13 May 2025, 11:36
THE GOLDMAN SACHS GROUP, INC.	6.6%		$104,385	112,242			$0.93	13G	31 Dec 2024	10 Feb 2025, 17:31